LENZ Therapeutics, Inc. Balance Sheet
LENZ / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
LENZ Therapeutics, Inc. had $306M in total assets and $284M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $25.2M | $20.2M | $35.1M | $47.7M | $377.0M | $19.8M |
| Accounts Receivable | $329.0K | - | - | - | - | - |
| Inventory | $2.9M | - | - | - | - | - |
| Current Assets | $301.4M | $211.9M | $67.2M | $275.4M | $381.7M | $21.1M |
| PP&E (Net) | $1.2M | $651.0K | $54.0K | $22.6M | $6.5M | $1.5M |
| Total Assets | $305.9M | $215.3M | $70.4M | $321.9M | $402.0M | $22.6M |
| Current Liabilities | $21.2M | $10.4M | $18.5M | $13.0M | $12.1M | $32.0M |
| Shareholders' Equity | $284.3M | $204.1M | -$92.7M | -$24.2M | $384.1M | -$65.4M |